Is Medtronic PLC Stock a Good Investment?
Medtronic PLC Investment Advice | MDT |
- Examine Medtronic PLC's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Medtronic PLC's leadership team and their track record. Good management can help Medtronic PLC navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Medtronic PLC's business and its evolving consumer preferences.
- Compare Medtronic PLC's performance and market position to its competitors. Analyze how Medtronic PLC is positioned in terms of product offerings, innovation, and market share.
- Check if Medtronic PLC pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Medtronic PLC's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Medtronic PLC stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Medtronic PLC is a good investment.
Sell | Buy |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Medtronic PLC Stock
Researching Medtronic PLC's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 85.0% of the company shares are owned by institutional investors. The book value of Medtronic PLC was now reported as 38.95. The company has Price/Earnings To Growth (PEG) ratio of 1.52. Medtronic PLC last dividend was issued on the 21st of March 2024. The entity had 2:1 split on the 27th of September 1999.
To determine if Medtronic PLC is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Medtronic PLC's research are outlined below:
| Medtronic PLC generated a negative expected return over the last 90 days | |
| Over 85.0% of the company shares are owned by institutional investors | |
| On 12th of April 2024 Medtronic PLC paid $ 0.69 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Telehealth, AI, and the evolution of remote surgical assistance |
Medtronic PLC Quarterly Liabilities And Stockholders Equity |
|
Medtronic PLC uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Medtronic PLC. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Medtronic PLC's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 20th of February 2024 Upcoming Quarterly Report | View | |
| 23rd of May 2024 Next Financial Report | View | |
| 31st of January 2024 Next Fiscal Quarter End | View | |
| 23rd of May 2024 Next Fiscal Year End | View | |
| 31st of October 2023 Last Quarter Report | View | |
| 30th of April 2023 Last Financial Announcement | View |
Earnings surprises can significantly impact Medtronic PLC's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Medtronic PLC's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2020-05-21 | 2020-04-30 | 0.68 | 0.58 | -0.1 | 14 | ||
2021-02-23 | 2021-01-31 | 1.15 | 1.29 | 0.14 | 12 | ||
2020-11-24 | 2020-10-31 | 0.8 | 1.02 | 0.22 | 27 | ||
2020-08-25 | 2020-07-31 | 0.18 | 0.62 | 0.44 | 244 |
Medtronic PLC Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Medtronic target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Medtronic PLC's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 33 | Buy |
Most Medtronic analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Medtronic stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Medtronic PLC, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationMedtronic PLC Target Price Projection
Medtronic PLC's current and average target prices are 79.74 and 90.44, respectively. The current price of Medtronic PLC is the price at which Medtronic PLC is currently trading. On the other hand, Medtronic PLC's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Medtronic PLC Market Quote on 29th of April 2024
Target Price
Analyst Consensus On Medtronic PLC Target Price
Medtronic PLC Analyst Ratings
Medtronic PLC's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Medtronic PLC stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Medtronic PLC's financials, market performance, and future outlook by experienced professionals. Medtronic PLC's historical ratings below, therefore, can serve as a valuable tool for investors.Know Medtronic PLC's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Medtronic PLC is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Medtronic PLC backward and forwards among themselves. Medtronic PLC's institutional investor refers to the entity that pools money to purchase Medtronic PLC's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Franklin Resources Inc | 2023-12-31 | 19.4 M | Deutsche Bank Ag | 2023-12-31 | 17.3 M | T. Rowe Price Associates, Inc. | 2023-12-31 | 15.4 M | Norges Bank | 2023-12-31 | 14.9 M | Wells Fargo & Co | 2023-12-31 | 13.1 M | Northern Trust Corp | 2023-12-31 | 12.7 M | Sanders Capital, Llc | 2023-12-31 | 12.6 M | Royal Bank Of Canada | 2023-12-31 | 12.6 M | Goldman Sachs Group Inc | 2023-12-31 | 12 M | Vanguard Group Inc | 2023-12-31 | 126.5 M | Blackrock Inc | 2023-12-31 | 118.6 M |
Medtronic PLC's market capitalization trends
The company currently falls under 'Mega-Cap' category with a total capitalization of 105.88 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medtronic PLC's market, we take the total number of its shares issued and multiply it by Medtronic PLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Market Cap |
|
Medtronic PLC's profitablity analysis
Medtronic PLC's profitability indicators refer to fundamental financial ratios that showcase Medtronic PLC's ability to generate income relative to its revenue or operating costs. If, let's say, Medtronic PLC is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Medtronic PLC's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Medtronic PLC's profitability requires more research than a typical breakdown of Medtronic PLC's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.11 | 0.18 | |
| Return On Capital Employed | 0.05 | 0.05 | |
| Return On Assets | 0.04 | 0.04 | |
| Return On Equity | 0.07 | 0.07 |
Determining Medtronic PLC's profitability involves analyzing its financial statements and using various financial metrics to determine if Medtronic PLC is a good buy. For example, gross profit margin measures Medtronic PLC's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Medtronic PLC's profitability and make more informed investment decisions.
The data published in Medtronic PLC's official financial statements usually reflect Medtronic PLC's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Medtronic PLC. For example, before you start analyzing numbers published by Medtronic accountants, it's critical to develop an understanding of what Medtronic PLC's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Medtronic PLC's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Medtronic PLC's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Medtronic PLC's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Medtronic PLC. Please utilize our Beneish M Score to check the likelihood of Medtronic PLC's management manipulating its earnings.
Evaluate Medtronic PLC's management efficiency
Medtronic PLC has Return on Asset of 0.0423 % which means that on every $100 spent on assets, it made $0.0423 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0817 %, implying that it generated $0.0817 on every 100 dollars invested. Medtronic PLC's management efficiency ratios could be used to measure how well Medtronic PLC manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.18 in 2024, whereas Return On Capital Employed is likely to drop 0.05 in 2024. Total Current Liabilities is likely to gain to about 10.9 B in 2024. Liabilities And Stockholders Equity is likely to gain to about 109.8 B in 2024| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 38.24 | 40.15 | |
| Net Current Asset Value | 0.00 | 0.00 | |
| Tangible Asset Value | 0.00 | 0.00 | |
| Tangible Book Value Per Share | (6.02) | (5.72) | |
| Enterprise Value Over EBITDA | 25.07 | 26.32 | |
| Price Book Value Ratio | 3.42 | 5.53 | |
| Enterprise Value Multiple | 25.07 | 26.32 | |
| Price Fair Value | 3.42 | 5.53 | |
| Enterprise Value | 179 B | 187.9 B |
The analysis of Medtronic PLC's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Medtronic PLC's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Medtronic Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield 0.0346 | Forward Dividend Yield 0.0346 | Forward Dividend Rate 2.76 | Beta 0.783 |
Basic technical analysis of Medtronic Stock
As of the 29th of April, Medtronic PLC secures the Risk Adjusted Performance of (0.04), mean deviation of 0.8222, and Standard Deviation of 1.09. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medtronic PLC, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to break down thirteen technical drivers for Medtronic PLC, which can be compared to its peers in the industry. Please verify Medtronic PLC mean deviation, treynor ratio, as well as the relationship between the Treynor Ratio and kurtosis to decide if Medtronic PLC is priced some-what accurately, providing market reflects its recent price of 79.74 per share. Given that Medtronic PLC has information ratio of (0.15), we recommend you to check Medtronic PLC's last-minute market performance to make sure the company can sustain itself at a future point.Medtronic PLC's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Medtronic PLC insiders, such as employees or executives, is commonly permitted as long as it does not rely on Medtronic PLC's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Medtronic PLC insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Robert White over six months ago Disposition of 12397 shares by Robert White of Medtronic PLC subject to Rule 16b-3 | ||
Brett Wall over six months ago Acquisition by Brett Wall of 13333 shares of Medtronic PLC subject to Rule 16b-3 |
Understand Medtronic PLC's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Medtronic PLC's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.07) | |||
| Mean Deviation | 0.8222 | |||
| Coefficient Of Variation | (1,486) | |||
| Standard Deviation | 1.09 | |||
| Variance | 1.19 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.22) | |||
| Treynor Ratio | (0.08) | |||
| Maximum Drawdown | 6.33 | |||
| Value At Risk | (1.95) | |||
| Potential Upside | 1.37 | |||
| Skewness | 0.33 | |||
| Kurtosis | 1.62 |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.07) | |||
| Mean Deviation | 0.8222 | |||
| Coefficient Of Variation | (1,486) | |||
| Standard Deviation | 1.09 | |||
| Variance | 1.19 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.22) | |||
| Treynor Ratio | (0.08) | |||
| Maximum Drawdown | 6.33 | |||
| Value At Risk | (1.95) | |||
| Potential Upside | 1.37 | |||
| Skewness | 0.33 | |||
| Kurtosis | 1.62 |
Consider Medtronic PLC's intraday indicators
Medtronic PLC intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Medtronic PLC stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Medtronic PLC Corporate Filings
F4 | 9th of April 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10Q | 27th of February 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 20th of February 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 14th of February 2024 An amended filing to the original Schedule 13G | ViewVerify |
Medtronic Stock media impact
Far too much social signal, news, headlines, and media speculation about Medtronic PLC that are available to investors today. That information is available publicly through Medtronic media outlets and privately through word of mouth or via Medtronic internal channels. However, regardless of the origin, that massive amount of Medtronic data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Medtronic PLC news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Medtronic PLC relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Medtronic PLC's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Medtronic PLC alpha.
Medtronic PLC Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Medtronic PLC can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Medtronic PLC Historical Investor Sentiment
Investor biases related to Medtronic PLC's public news can be used to forecast risks associated with an investment in Medtronic. The trend in average sentiment can be used to explain how an investor holding Medtronic can time the market purely based on public headlines and social activities around Medtronic PLC. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Medtronic PLC's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Medtronic PLC and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Medtronic PLC news discussions. The higher the estimate score, the more favorable the investor's outlook on Medtronic PLC.
Medtronic PLC Maximum Pain Price across 2024-05-03 Option Contracts
Medtronic PLC's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Medtronic PLC close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Medtronic PLC's options.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Medtronic PLC without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Medtronic PLC Corporate Directors
Medtronic PLC corporate directors refer to members of a Medtronic PLC board of directors. The board of directors generally takes responsibility for the Medtronic PLC's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Medtronic PLC's board members must vote for the resolution. The Medtronic PLC board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Scott Donnelly | Lead Independent Director | Profile | |
| Richard Anderson | Lead Independent Director | Profile | |
| Elizabeth Nabel | Independent Director | Profile | |
| James Lenehan | Independent Director | Profile |
How to buy Medtronic Stock?
To provide specific investment advice or recommendations on Medtronic PLC stock, we recommend investors consider the following general factors when evaluating Medtronic PLC. This will help you to make an informed decision on whether to include Medtronic PLC in one of your diversified portfolios:- Examine Medtronic PLC's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Medtronic PLC's leadership team and their track record. Good management can help Medtronic PLC navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Medtronic PLC's business and its evolving consumer preferences.
- Compare Medtronic PLC's performance and market position to its competitors. Analyze how Medtronic PLC is positioned in terms of product offerings, innovation, and market share.
- Check if Medtronic PLC pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Medtronic PLC's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Medtronic PLC stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Medtronic PLC is a good investment.
Already Invested in Medtronic PLC?
The danger of trading Medtronic PLC is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Medtronic PLC is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Medtronic PLC. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Medtronic PLC is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Medtronic PLC is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Medtronic Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Medtronic Plc Stock. Highlighted below are key reports to facilitate an investment decision about Medtronic Plc Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.Note that the Medtronic PLC information on this page should be used as a complementary analysis to other Medtronic PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Medtronic Stock analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Medtronic PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medtronic PLC. If investors know Medtronic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medtronic PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.078 | Dividend Share 2.75 | Earnings Share 3.15 | Revenue Per Share 24.298 | Quarterly Revenue Growth 0.047 |
The market value of Medtronic PLC is measured differently than its book value, which is the value of Medtronic that is recorded on the company's balance sheet. Investors also form their own opinion of Medtronic PLC's value that differs from its market value or its book value, called intrinsic value, which is Medtronic PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medtronic PLC's market value can be influenced by many factors that don't directly affect Medtronic PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Medtronic PLC's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Medtronic PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medtronic PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.